TAB Diagnostic

TAB Diagnostic, Inc. is a non-invasive diabetes testing and monitoring company developing the first portable saliva-based test focusing on detection for minorities with the risk that the A1c test can be unreliable for diagnosing or monitoring. 8.5 million adults are estimated to have undiagnosed diabetes (23% of all adults with diabetes). And over 76 million adults living with pre-diabetes are unaware. The Oral Glucose Tolerance Test (OGTT) is the most sensitive test for detecting diabetes; however, the test is inconvenient and costly. Minorities have additional risks using A1c alone for detection with its known shortcomings that can result in delayed or missed diagnosis. TAB Dx's portable saliva test is a simple, accurate, pathogenically relevant, easy-to-use diagnostic test that could efficiently screen in almost any setting, removing the time and cost barrier in diabetes diagnosis and screening tests.